Assessing the Burden of Leishmaniasis
Author Information
Author(s): Richard Reithinger, Utzinger Juerg
Primary Institution: London School of Hygiene and Tropical Medicine
Hypothesis
How can the burden of leishmaniasis be quantified more accurately?
Conclusion
The current estimates of the disease burden of leishmaniasis are outdated and likely underrepresent the true impact.
Supporting Evidence
- Current methods of assessing disease burden fail to account for clinical and epidemiological diversity.
- Estimates of leishmaniasis burden are outdated and unclear.
- 90% of visceral leishmaniasis cases occur in specific countries.
- Leishmaniasis is the third most important vector-borne disease in terms of disability adjusted life years.
Takeaway
Leishmaniasis is a disease that affects many people, but we don't have accurate numbers on how many are sick or how serious it is, so we need to do better at counting.
Methodology
The article reviews existing data on morbidity, mortality, and socioeconomic impact of leishmaniasis.
Potential Biases
There is a risk of underreporting and misdiagnosis due to similarities with other diseases.
Limitations
The estimates of disease burden are based on outdated data and may not reflect current realities.
Participant Demographics
Leishmaniasis is endemic in 88 countries, affecting various age groups, particularly in endemic regions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website